Fatigue News and Research

RSS

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

UCB announced today results from a post hoc analysis of the RAPID 1 study published in the Journal of Rheumatology. The results suggest moderate to severe rheumatoid arthritis patients treated with Cimzia, the only approved PEGylated anti-TNF, together with methotrexate, achieved a rapid response associated with improved long-term outcomes one year after treatment began.

11 May 2011

Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment

Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced that applications for market approval for vemurafenib for the treatment of metastatic melanoma have been submitted to the U.S. Food and Drug Administration and the European Medicines Agency.

11 May 2011

AOBO's ZD Pill and CWJ Tablet receive Chinese approval for sales in Hong Kong

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that the Company's Zhibai Dihuang Pill and Ciwujia Tablet have been approved for sale as traditional Chinese medicine in Hong Kong by Chinese Medicine Council of Hong Kong.

10 May 2011

Parasites in human waste fertilizers alarm health experts

It has been suggested that human faeces used as fertiliser on farms are leading to the spread of ‘Third World’ parasites causing a serious stomach illness across Sydney.

8 May 2011

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

On Thursday, the U.S. Food and Drug Administration approved Afinitor (everolimus) to treat patients with progressive neuroendocrine tumors located in the pancreas (PNET) that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

7 May 2011

ImmunoCellular reports updated ICT-107 Phase I trial data in glioblastoma multiforme

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced updated long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme, the most common and aggressive form of brain cancer.

6 May 2011

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.

6 May 2011

$Study: Bisphosphonates can cause fatigue fractures$

Study: Bisphosphonates can cause fatigue fractures

Bisphosphonates are a medication that has been administered since the 1990s, which reduces the overall risk of brittleness and incidence of osteoporosis. Bisphosphonates deactivate those cells used to break down bone and therefore prevent fractures caused by brittleness of the bone.

5 May 2011

Study: XMRV retrovirus is not present in chronic fatigue syndrome patients

New findings from University of Utah School of Medicine researchers show that the retrovirus called XMRV is not present in the blood of patients who have chronic fatigue syndrome.

5 May 2011

Mental Illness Foundation invites Quebecers to be attentive to loved ones

As part of the 60th National Mental Health Week, which runs from May 1 to 7, 2011, the Mental Illness Foundation invites Quebecers to take action and be attentive to loved ones coping with a mental illness and underlines that the search for good mental health is one of the protective factors in preventing mental illness.

2 May 2011

Low vitamin D levels linked to anemia in children

Pediatricians from Johns Hopkins Children's Center and elsewhere have discovered a link between low levels of vitamin D and anemia in children.

2 May 2011

Addison's patients with low cortisol levels more likely to get infections

Two new studies presented at the European Congress of Endocrinology in Rotterdam show the possible dangers facing patients with Addison's disease are higher than previously thought.

2 May 2011

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Eli Lilly Canada announced today that Health Canada has approved Cymbalta for the management of chronic low back pain.

30 Apr 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.

29 Apr 2011

Study finds increase in obesity prevalence among adults with arthritis

People with arthritis are significantly more likely to be obese than those without the disease and the rate among them is increasing in far more states than it is decreasing, cites new CDC data released in conjunction with National Arthritis Awareness Month in May.

29 Apr 2011

More women using ‘morning after’ pill

Figures have revealed that the rate of women using emergency contraception in 2006-08 more than doubled, compared with the rate in the previous four to six years, before the pills were approved for use without a prescription. This comes from a study from the Guttmacher Institute.

29 Apr 2011

Curis reports first quarter net loss of $6.8 million

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the first quarter ended March 31, 2011.

28 Apr 2011

New microchip sensor can detect individual's respiratory rate

Researchers at Tyndall National Institute, UCC, Cork, have developed a microchip sensor that can detect a person's respiratory rate without any contact with the person under observation.

28 Apr 2011

Tsetse fly mapping distribution model may help solve sleeping sickness mystery

Since before the 1300s, people living in many parts of Africa have been dying from a disease known as sleeping sickness. Despite public health campaigns that explain ways to stop infection—primarily by killing the disease-spreading tsetse fly—successful eradication has remained out of reach. That's partly because epidemiologists can't predict where cases will emerge next.

28 Apr 2011

Kava tea may cause kidney failure and muscle breakdown

When a 34-year-old bicyclist was found collapsed on a roadside and rushed to the University of Rochester Medical Center emergency room on the verge of kidney failure and muscle breakdown, doctors were surprised to discover that a trendy tea derived from the kava plant was the cause of his ills.

28 Apr 2011